Related Experiment Video
Updated: Aug 16, 2026

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
Kasabach-Merritt phenomenon
Khalid A Al-Mazrou1, Mark A Richardson
1Department of ORL, King Saud University and University Hospitals, Riyadh, Kingdom of Saudi Arabia. kmazrou@ksu.edu.sa
Abstract:
An association between a vascular lesion and a life threatening coagulopathy is called Kasabach-Merritt phenomenon (KMP). It includes thrombocytopenia, microangiopathic hemolytic anemia, and disseminated intravascular coagulopathy. We cannot overstate the need for excellent and careful screening. Treatment modalities of KMP have included medication, radiation, embolization and surgery. Corticosteroids have traditionally been the mainstay of treatment. We report a 4-month-old girl with an extensive vascular lesion involving the left parotid, submandibular, and parapharyngeal regions, and with KMP. We treated her with a mega dose of corticosteroids. Her coagulopathy resolved, and her vascular lesion improved.
Insights
Kasabach-Merritt phenomenon (KMP), a serious vascular lesion complication, can be effectively treated. Mega-dose corticosteroids resolved coagulopathy and improved the vascular lesion in a pediatric case.
Area of Science:
- Vascular Medicine
- Pediatric Hematology
- Oncology
Background:
- Kasabach-Merritt phenomenon (KMP) is a rare, life-threatening coagulopathy associated with vascular tumors.
- KMP presents with thrombocytopenia, microangiopathic hemolytic anemia, and disseminated intravascular coagulopathy.
- Traditional treatments include medication, radiation, embolization, and surgery, with corticosteroids as a mainstay.
Observation:
- A 4-month-old infant presented with an extensive vascular lesion in the head and neck.
- The infant also exhibited symptoms consistent with Kasabach-Merritt phenomenon.
- Screening for KMP is critical due to its severity.
Findings:
- The patient was treated with mega-dose corticosteroids.
- The corticosteroid treatment led to the resolution of the infant's coagulopathy.
- Significant improvement in the size and extent of the vascular lesion was observed.
Implications:
- Mega-dose corticosteroids represent a viable and effective treatment for Kasabach-Merritt phenomenon in infants.
- This approach offers a less invasive option compared to surgery or embolization.
- Further research into optimal corticosteroid dosing and long-term outcomes is warranted.
More Related Videos
Related Concept Videos
Correspondence Bias
Magical Thinking
Tip-of-the-Tongue Phenomenon
Cause and Effect
Actor-Observer Effect
The Availability Heuristic

